Aboriginal people key to fight HIV/AIDS

Indigenous groups getting a voice at the International AIDS Conference

Now, more than ever, Aboriginal Peoples are being recognized as a key population in the fight against HIV/AIDS.

While on the international stage, Canada is seen as a country that supports indigenous groups’ work to end HIV/AIDS; it’s also used as a warning to other nations to show the need to get culturally appropriate programing of HIV prevention to First Nation communities.

“For me as an Aboriginal Australian, looking at the HIV data from Canada is a real concern for me,” said James Ward, an associate professor in Australia and first-ever indigenous plenary speaker, at the recent International AIDS Conference in Melbourne. “When you represent 4 per cent of the population and 23 per cent of all HIV diagnosis in that country it’s of real concern.”

Angela Hill
Eagle Feather News
Read The Full Story

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below